Defense Health Agency

Organisation

Awards made

  • Ohio State University

    The menopause transition and the gut-brain-axis: an observational study of hormones, microbiota, stress, and mood, HT9425261E470, US$3.1m, 2026–2030, 1 Sept 2026

  • University of Miami School of Medicine

    Bringing alzheimers detection to the front lines evaluating novel cognitive and plasma biomarkers in primary care, HT9425261E260, US$602.8k, 2026–2030, 4 Jun 2026

  • University of Miami School of Medicine

    Bringing alzheimer's detection to the front lines: evaluating novel cognitive and plasma biomarkers in primary care., HT9425261E257, US$1.1m, 2026–2030, 4 Jun 2026

  • Columbia University Health Sciences

    The value of hypertension control to prevent dementia and enhance readiness: generating evidence from dod-vha data, patient preferences and health economics, HT9425261E143, US$301.6k, 2026–2029, 1 May 2026

  • University of Utah

    The value of hypertension control to prevent dementia and enhance readiness: generating evidence from dod-vha data, patient preferences and health economics., HT9425261E142, US$695.3k, 2026–2029, 1 May 2026

  • Boston VA Research Institute

    Hemoglobin a1c stability and dementia in older adults with diabetes, HT9425261E131, US$997.4k, 2026–2029, 20 Apr 2026

  • Henry Ford Health System

    Translating digital wrist tomosynthesis as a novel diagnostic aid to enable osteoporosis screening within the widely accessible mammography setting, HT9425261E066, US$3.3m, 2026–2030, 24 Mar 2026

  • Wayne State University

    Biological vs chronological aging: effects on mobility and cognition in multiple sclerosis, HT94252510996, US$319.6k, 2025–2027, 25 Aug 2025

  • Johns Hopkins University

    Social determinants of health, biological aging, and disease course in multiple sclerosis, HT94252510920, US$320.2k, 2025–2027, 20 Aug 2025

  • New York University School of Medicine

    The impact of hematopoietic aging on alzheimers disease development, HT94252510757, 2025–2028, 21 Jul 2025

  • New York University School of Medicine

    The impact of hematopoietic aging on alzheimer's disease development, HT94252510758, 2025–2028, 21 Jul 2025

  • University of Pennsylvania

    Associations of blood-based neurodegenerative biomarker trajectories with epilepsy, post-traumatic epilepsy, and dementia risk, HT94252510239, US$777.5k, 2025–2028, 2 Jul 2025

  • Florida State University

    Daily patterns and predictors of cognitive function in middle-aged and older adults with neurofibromatosis type 1: an ecological momentary assessment stud, HT94252510362, US$885.5k, 2025–2028, 2 Jul 2025

  • Johns Hopkins University

    The aging microenvironment as a driver of pancreatic cancer metastasis, HT94252510657, US$388.2k, 2025–2028, 1 Jul 2025

  • Johns Hopkins University

    The aging microenvironment as a driver of pancreatic cancer metastasis, HT94252510664, US$610.1k, 2025–2028, 1 Jul 2025

  • University of Kansas Medical Center

    The biology of frailty in people with multiple sclerosis, HT94252510601, US$250k, 2025–2027, 30 Jun 2025

  • Roskamp Institute

    Delineating the therapeutic effect of a novel bbb-penetrable ppar agonist on chronic outcomes following age-related repetitive mild tbi, HT94252510321, US$3.3m, 2025–2029, 27 May 2025

  • University of Florida

    Alcohol use as a moderating factor in serotonergic neurodegeneration in the early stages of alzheimer's disease, HT94252510432, US$996.6k, 2025–2028, 7 May 2025

  • Salisbury Foundation for Research and Education

    Relationship between blast exposure and cellular senescence in veterans, HT94252510407, US$1.9m, 2025–2029, 6 May 2025

  • Univ of Massachusetts Med Sch Worcester

    Crispr-based adipose therapies for accelerated aging in irradiated nonhuman primates., HT94252510247, US$5.7m, 2025–2028, 3 Apr 2025

Sources: usaspending.gov

Papers